A week ago, Aclaris Therapeutics, Inc. ( NASDAQ:ACRS ) came out with a strong set of first-quarter numbers that could...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.23835, expectations were $-0.28. Aclaris Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
Q1 2024 Aclaris Therapeutics Inc Earnings Call